Study Stopped
Per Endocrinology study team, COVID prevented enrollment, and then PI left institution.
Lean Diabetes Study
1 other identifier
observational
N/A
1 country
1
Brief Summary
Systematic assessment of perinatal, behavioral and genetic risk factors will be evaluated in an underserved population with lean diabetes (LDM) as compared to a control population with obese type 2 diabetes (ODM).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2022
CompletedFirst Submitted
Initial submission to the registry
June 2, 2022
CompletedFirst Posted
Study publicly available on registry
June 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2023
CompletedJuly 25, 2024
July 1, 2024
1.4 years
June 2, 2022
July 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
HOMA Index and Beta cell function
Single visit study
Secondary Outcomes (3)
Prevalence of high risk behaviors
Single visit study
Prevalence of perinatal malnutrition
Single visit study
MODY probability >25%
Single visit study
Study Arms (2)
LDM
Lean Diabetes Mellitus
ODM
Obese Diabetes Mellitus
Interventions
Eligibility Criteria
35 adults with LDM (BMI \<25) will be compared to age, gender and duration of diabetes matched control population of 35 ODM (BMI \>30) adults recruited from the CCH outpatient clinics.
You may not qualify if:
- individuals \<20 years of age, currently pregnant or undergoing chemotherapy, those on glucocorticoid therapy; history of bariatric surgery or pancreatitis; known positive antipancreatic antibodies; individuals with a BMI between 25.0-29.9, A1c \>10%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cook County Health
Chicago, Illinois, 60612, United States
Biospecimen
Saliva collection
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 2, 2022
First Posted
June 7, 2022
Study Start
March 15, 2022
Primary Completion
July 26, 2023
Study Completion
July 26, 2023
Last Updated
July 25, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share